CLINICAL MICROSCOPY (Urinalysis)

131
URINALYSIS By Roderick D. Balce, RMT

description

Study guide in Clinical Microscopy (Urinalysis) for Medical technology students

Transcript of CLINICAL MICROSCOPY (Urinalysis)

Page 1: CLINICAL MICROSCOPY (Urinalysis)

URINALYSISBy

Roderick D. Balce, RMT

Page 2: CLINICAL MICROSCOPY (Urinalysis)

ANATOMY OF THE KIDNEY

Page 3: CLINICAL MICROSCOPY (Urinalysis)

Afferent arteriolesEfferent arteriolesPeritubular capillariesProximal convoluted tubuleDistal convoluted tubuleVasa rectaAscending loop of HenleDescending loop of Henle

RENAL FUNCTIONS

1. Renal Blood Flow

Page 4: CLINICAL MICROSCOPY (Urinalysis)

2. Glomerular Filtration Glomerulus GFR = 120 ml/min Factors Affecting Glomerular Filtration

a. Cellular structure Capillary Wall Membrane Basement Membrane Visceral Epithelium

b. Hydrostatic pressure Blood Colloidal Oncotic Pressure Capsular Pressure

c. Renin-Angiotensin-Aldosterone Mechanism

Page 5: CLINICAL MICROSCOPY (Urinalysis)

3. Tubular Reabsorption Mechanisms involved:

a. Active Transport Actively transported: Glucose,

Amino acids Salts

Chloride Sodium

Renal threshold –important in distinguishing between: Excess solute filtration Renal tubular damage

Page 6: CLINICAL MICROSCOPY (Urinalysis)

b. Passive TransportPassively Transported: Water

Urea Sodium

c. Counter-Current MechanismOsmotic Gradient of Medulla

Vasopressin

Page 7: CLINICAL MICROSCOPY (Urinalysis)

4. Tubular SecretionMajor Functions:

a. Elimination of waste products not filtered by the glomerulus

b. Regulation of acid-base balance through secretion of H ions

Page 8: CLINICAL MICROSCOPY (Urinalysis)

Renal Function Tests1. Glomerular Filtration Test

Clearance testa. Ureab. Radioisotopec. B2 microglobulind. Creatinine C = UV/P Normal values: Creatinine Clearance: F = 75-112 ml/m

M = 85-125 ml/m Plasma Creatinine = 0.5-1.5 mg/dle. Inulin

Page 9: CLINICAL MICROSCOPY (Urinalysis)

2. Tubular Reabsorption Tests a. Fishberg Testb. Mosenthal Test

c. Osmometry

3. Tubular Secretion and Renal Blood Flow Tests

a. PAHb. PSPc. Indigo Carmine Test

Page 10: CLINICAL MICROSCOPY (Urinalysis)

Renal DiseasesA. Glomerular Disorders:1. Glomerulonephritis – blood, protein, and casts

in urinea. Acute Poststreptococcal – caused by

deposition of immune complexes and antibodies in the glomerular

membrane following group A streptococcal infection.

b. Rapidly Progressive ( Crescentic) – more serious, can lead to renal failure; arises as a result of another form of glomerulonephritis or an immune systemic disorder.

Page 11: CLINICAL MICROSCOPY (Urinalysis)

c. Good Pasture’s Syndrome – attachment of cytotoxic autoantibody (anti-glomerular

basement membrane antibody) to the glomerular and alveolar basement membranes during viral respiratory infections.

Lab Findings:proteinuria, hematuria, RBC casts

2. Vasculitis - immune-mediated disoders affecting the systemic vascular system resulting to

glomerular damage.

Page 12: CLINICAL MICROSCOPY (Urinalysis)

a. Wegener’s granulomatosis – granuloma- producing inflammation of the small blood vessels in the lungs and kidney.The antibody causing the damage is the anti-neutrophilc cytoplasmic antibody (ANCA) Lab findings: hematuria, proteinuria, rbc casts,

and increased BUN and crea

b. Henoch-Schonlein Purpura – characterized by a decrease in platelets that causes disruption of vascular integrity Lab findings: heavy proteinuria and hematuria

with rbc casts

Page 13: CLINICAL MICROSCOPY (Urinalysis)

Wegener’s Granulomatosis

Page 14: CLINICAL MICROSCOPY (Urinalysis)
Page 15: CLINICAL MICROSCOPY (Urinalysis)

3. Immunoglobulin A nephropathy

- deposition of immune complexes on the glomerular membrane resulting from increased levels of serum IgA Lab findings: macroscopic/microscopic

hematuria and increased IgA

4. Membranous Glomerulonephritis

- thickening of the glomerular membrane due to deposition of IgG immune complexes. Lab findings: microscopic hematuria and

increased IgG and protein excretion

Page 16: CLINICAL MICROSCOPY (Urinalysis)

5. Membranoproliferative Glomerulonephritis – immune mediated disorder characterized by cellular proliferation in capillary walls or glomerular basement membrane.

Lab findings: hematuria, proteinuria, and decreased serum complement levels

6. Chronic Glomerulonephritis – glomerular damage as a result of other renal disorders leads to marked decrease in renal functions and eventually to renal failure Lab findings: hematuria, proteinuria, glucosuria,

varieties of casts including broad cast, markedly decreased GFR with increased BUN and crea levels, and electrolyte imbalance

Page 17: CLINICAL MICROSCOPY (Urinalysis)

7. Nephrotic Syndrome – disruption in the electrical charges in the basal lamina and podocytes, producing a less tightly connected barrier. Lab Findings: massive proteinuria, low albumin, high

serum levels of lipids, and pronounced edema

8. Minimal Change Disease – podocytes appear to be less tightly fitting allowing increased filtration of protein; seen in children

following allergic reaction and immunization. Lab Findings: edema, heavy proteinuria, transient

hematuria

Page 18: CLINICAL MICROSCOPY (Urinalysis)

9. Focal Segmental Glomerulosclerosis- only a certain number and areas of

glomeruli are affected. The disease is caused by disruption of the podocytes associated with analgesics and heroin abuse and AIDS. Immunoglobulins M and C3 are seen in undamaged

glomeruli.•Lab Findings: heavy proteinuria, microscopic hematuria

Page 19: CLINICAL MICROSCOPY (Urinalysis)

II. Tubulointerstitial Disorders 1. Acute Tubular Necrosis – damage to the

renal tubular cells by toxic agents or ischemia

2. Fanconi’s Syndrome – generalized failure of tubular reabsorption in the PCT;

may be hereditary or acquired

Page 20: CLINICAL MICROSCOPY (Urinalysis)

3. Cystitis – ascending bacterial infection of the bladder

4. Acute Pyelonephritis – infection of the upper urinary tract involving the interstitium

and tubules due to interference of urine flow to the bladder, reflux of urine from the bladder, or untreated cystitis

5. Chronic Pyelonephritis – recurrent infection of the tubules and interstitium caused

by structural abnormalities affecting urine flow

6. Acute Interstitial Nephritis – inflammation of the renal interstitium associated with allergic reaction to medications

Page 21: CLINICAL MICROSCOPY (Urinalysis)

C. Vascular Disorders1. Renal Failure – may be gradual progression

from the original disorder to chronic renal failure or end-stage renal disease.

2. Renal Lithiasis – deposition of renal calculi or kidney stones in the calyces and pelvis of the kidney, ureters and urinary bladder.

Page 22: CLINICAL MICROSCOPY (Urinalysis)
Page 23: CLINICAL MICROSCOPY (Urinalysis)

Chemical Composition of Renal Calculi:

a. Calcium oxalate or phosphate

b. Magnesium ammonium phosphate

c. Uric acid

d. Cystine

Lab Findings: microscopic hematuria

Page 24: CLINICAL MICROSCOPY (Urinalysis)

Composition of Urine

1. water

2. analytes organic inorganic

3. hormones, vitamins, medications, formed elements, etc.

Page 25: CLINICAL MICROSCOPY (Urinalysis)

Timed Specimen: 24-hour Quantitative chemical tests,

hormone studies

12-hour Addis count

2-hr Postprandial Diabetic monitoring

Afternoon Specimen Urobilinogen determination

Glucose Tolerance Test Accompaniment to blood samples in GTT

Types of Urine Specimens

Page 26: CLINICAL MICROSCOPY (Urinalysis)

Random Routine screeningFirst Morning Routine screening

Pregnancy TestsOrthostatic Proteinuria

Fasting/Second Morning Diabetic screening / monitoring

Catheterized Bacterial cultureMidstream clean-catch Routine screening

Bacterial cultureSuprapubic aspiration Bladder urine for bacterial

cultureCytology

Three-glass collection Prostatic infectionDrug Specimen Drug testing

Page 27: CLINICAL MICROSCOPY (Urinalysis)
Page 28: CLINICAL MICROSCOPY (Urinalysis)

Voiding cystourethrogramExamining bladder function by injecting dye that is

visible on X-rays through a catheter to fill the bladder. X-rays are taken while the bladder is full and while the patient is urinating to determine if

fluid is forced out of the bladder through the urethra (normal) or up through the ureters into the

kidney (vesicoureteral reflux).

Page 29: CLINICAL MICROSCOPY (Urinalysis)

DRUG SPECIMEN COLLECTION

Chain of Custody (COC) Form the process that provides the

documentation of proper sample identification from the time of collection to the receipt of laboratory results

a standardized form that documents that the specimen collected by the patient is the same one that is analyzed and reported

Page 30: CLINICAL MICROSCOPY (Urinalysis)

Urine Specimen Collection

- the most vulnerable part of a drug testing program

- may be witnessed or unwitnessed; a same-gender collector is required in witnessed collection

Required Volume - 30-45 ml taken within 4 minutes

Temperature - 32.5ºC to 37.7ºC

Page 31: CLINICAL MICROSCOPY (Urinalysis)

Procedure: The collector washes hands, wears

gloves, adds bluing agent or dye to the toilet water reservoir, and tapes the toilet lid and faucet handles.

The donor provides identification from employer.

The collector completes step 1 COC Form and has the donor sign the form.

Page 32: CLINICAL MICROSCOPY (Urinalysis)

The donor leaves all his belongings outside, washes hands, and receives a specimen cup.

The collector remains in the restroom, outside the stall (unwitnessed) listening for unauthorized water use.

The donor hands specimen cup to the collector and the latter checks the urine for abnormal color and for the required amount.

The collector checks the temperature using a temperature strip, records the reading on the COC Form (step 2). If the temperature is out of range, recollection is needed.

Page 33: CLINICAL MICROSCOPY (Urinalysis)

With the donor watching, the collector seals the capped bottle with identification strips (COC step 3) covering both sides of the cup. The seals contain the date and time.

The donor initials the seals and completes COC step 4 after which, the collector accomplishes COC step 5.

Each time the specimen is handled, transferred or stored, every individual must be identified, the date and purpose of the change must be recorded, and specific instructions on labeling, packaging or transport must be followed.

Page 34: CLINICAL MICROSCOPY (Urinalysis)

Methods of Preservation1. Physical (Refrigeration)

2. Chemical Phenol – causes an odor change Toluene –not effective for bacteria and molds Thymol crystals – preserves glucose and

sediments well Formalin – excellent sediment preservative Boric acid – preserves protein well Sodium fluoride – good for drug analysis Sacomanno’s fixative – preserves cellular

elements

Page 35: CLINICAL MICROSCOPY (Urinalysis)

Changes in Unpreserved Urine Color - modified

or darkened

Increased:OdorpHNitriteBacteria

Decreased:ClarityGlucoseKetonesBilirubinUrobilinogenRed blood cellsWhite blood cellsCasts

Page 36: CLINICAL MICROSCOPY (Urinalysis)

Clinical Utilities of Routine Urinalysis

Indicators of the State of the Kidney or Urinary TractAppearance Specific GravityChemical testsLeukocyte EsteraseUrinary Sediment

Page 37: CLINICAL MICROSCOPY (Urinalysis)

Indicators of Metabolic and Other Conditions or DiseasepHAppearanceGlucose and KetonesBilirubinUrobilinogen

Page 38: CLINICAL MICROSCOPY (Urinalysis)

Indications of Other Systemic (Nonrenal) Conditions or DiseaseHemoglobinMyoglobinLight-chain proteinsPorphobilinogen

Page 39: CLINICAL MICROSCOPY (Urinalysis)

PHYSICAL EXAMINATION

Page 40: CLINICAL MICROSCOPY (Urinalysis)

I. VolumeAverage daily output: 1,200-1,500 mlVariations:

a. Polyuria Indications: Diabetes mellitus

Diabetes insipidus

b. Diuresisc. Oliguriad. Anuriae. Nocturia

Page 41: CLINICAL MICROSCOPY (Urinalysis)

II. Specific Gravity Performed using:

a. Urinometer Corrections done

b. Refractometer Instrument Calibration

c. Reagent strip

d. Harmonic Oscillation Densitometry

Page 42: CLINICAL MICROSCOPY (Urinalysis)

Variations in S.G.:a. Hypersthenuriab. Hyposthenuriac. Isosthenuria

III. pH

IV. Color• Pigments

Page 43: CLINICAL MICROSCOPY (Urinalysis)

Variations in Color: Colorless Pale yellow Dark yellow Orange Red/

Reddish brown Amber/Orange

Yellow green/

Yellow brown Green Blue green Milky white Pink/Red Brown/Black

Page 44: CLINICAL MICROSCOPY (Urinalysis)

V. Odor Normal: Aromatic

Variations in Urine Odor:

Amoniacal/Putrid/Foul

Mercaptan Fecaloid Fruity, sweet Maple syrup Sulfur odor

Mousy Rancid Sweaty feet Rotting fish Cabbage Bleach

Page 45: CLINICAL MICROSCOPY (Urinalysis)

VI. TransparencyUrine ClarityClear No visible particulates, transparent

Hazy Few particulates, print easily seen through urine

Cloudy Many particulates, print blurred through urine

Turbid Print cannot be seen through urine

Milky May precipitate or be clotted

Nubecula

Page 46: CLINICAL MICROSCOPY (Urinalysis)

Nonpathologic Causes of Urine Turbidity

Epithelial cells Normal crystals Bacteria (old urine) Semen, prostatic fluid Fecal contamination Radiographic contrast media, mucus,

talcum powder Vaginal creams

Page 47: CLINICAL MICROSCOPY (Urinalysis)

Pathologic Causes of Urine Turbidity

Red blood cells White blood cells Bacteria Yeasts Nonsquamous epithelial cells Abnormal crystals Casts Lymph fluid/Chyle Lipids Fecal matter

Page 48: CLINICAL MICROSCOPY (Urinalysis)

CHEMICAL ANALYSIS

Page 49: CLINICAL MICROSCOPY (Urinalysis)

I. pH Normal values: average-6; random-4.5-8.0;

fasting-5.5-6.5 Clinical Significance

a. respiratory or metabolic acidosis/ketosisb. respiratory or metabolic alkalosisc. renal tubular acidosisd. renal calculi formatione. treatment of UTIf. precipitation/identification of crystalsg. determination of unsatisfactory specimen

Page 50: CLINICAL MICROSCOPY (Urinalysis)

Causes of Acid and Alkaline Urine

Acid Urine Alkaline Urine Emphysema Hyperventilation Diabetes mellitus Vomiting Starvation Renal tubular acidosis Dehydration Presence of urease-

producing bacteria Diarrhea Vegetarian diet Presence of Old specimens

acid-producing

bacteria High protein diet Cranberry juice Medications

Page 51: CLINICAL MICROSCOPY (Urinalysis)

II. Protein Most indicative of renal disease Normal urine contains <10 mg/dl or 100 mg/24

hours Types of Proteinuria (according to the amount of

protein excreted per day)

Degree of Grams Excreted Proteinuria per 24 hours

Mild <1 g/dayModerate 1- 4 g/day Heavy >4 g/day

Page 52: CLINICAL MICROSCOPY (Urinalysis)

Types of Proteinuria (according to cause)

1. Pre-renal Intravascular hemolysisMuscle injurySevere infection and inflammationMultiple myeloma

Page 53: CLINICAL MICROSCOPY (Urinalysis)

2. Renal a. Glomerular

Conditions that cause damage to the glomerulus Orthostatic or Postural Proteinuria

b. Tubular

• Fanconi’s Syndrome

• Toxic agents/Heavy metals

• Severe viral infections

Page 54: CLINICAL MICROSCOPY (Urinalysis)

3. Post-renala. lower UTI/inflammation

b. injury/trauma

c. menstrual contamination

d. prostatic fluid/spermatozoa

e. vaginal secretions

Page 55: CLINICAL MICROSCOPY (Urinalysis)

Tests for Albumin Heat and Acetic Acid Test

Positive Results: 1+ - diffused cloud

2+ - granular cloud

3+ - distinct flocculi

4+ - large flocculi Reagent Strips SSA/Cold Protein Precipitation

Correlation of Reagent Strip and SSA Results

(+) Rgt. Strip, (-) SSA = albumin present

(+) Rgt. Strip, (+)SSA = proteinuria

(-) Rgt. Strip, (+) SSA = BJP, globulins, etc.

Page 56: CLINICAL MICROSCOPY (Urinalysis)

III. Glucose Normal concentration: 15 mg/dl Melituria Glycusoria Clinical significance

a. DMb. endocrine disordersc. pancreatitis, carcinoma, cystic fibrosis,

hemochromatosisd. CNS disorderse. disturbance in metabolismf. liver diseaseg. renal glycusoriah. drugs

Page 57: CLINICAL MICROSCOPY (Urinalysis)

Glycusoria without hyperglycemia

a. renal tubular dysfunction

b. tubular necrosis

c. Fanconi’s syndrome

Tests for Glucose

1.Benedict’s Test – general test for glucose and other reducing sugars

2. Clinitest – subject to interference from other reducing sugars

• Pass-though phenomenon

3. Glucose Oxidase – specific for glucose

Page 58: CLINICAL MICROSCOPY (Urinalysis)

Correlation of Glucose Oxidase and Clinitest

GOD Clinitest Interpretation 1+ neg small amount of glucose

present

4+ neg possible oxidizing agent interference on rgt

strip

neg 1+ non-glucose reducing substance

present

Page 59: CLINICAL MICROSCOPY (Urinalysis)

IV. Ketones Represents 3 intermediate products of fat

metabolism:

a. acetone

b. acetoacetic acid

c. β-hydroxybutyric acid

Accumulation in blood leads to:

a. electrolyte imbalance

b. dehydration

c. acidosis

d. diabetic coma

Page 60: CLINICAL MICROSCOPY (Urinalysis)

Clinical significance:a. DM

b. insulin dose monitoring

c. diabetic acidosis

d. starvation/fasting

e. weight reduction/dieting/strenuous exercise

f. vomiting

g. malabsorption/pancreatic disorders

h. inborn error of amino acid metabolism

Page 61: CLINICAL MICROSCOPY (Urinalysis)

V. BloodHematuria

Clinical Significance:a. renal calculib. glomerulonephritisc. tumorsd. traumae. pyelonephritisf. toxic chemicalsg. strenuous sxerciseh. menstrual contamination

Page 62: CLINICAL MICROSCOPY (Urinalysis)

Hemoglobinuria

Clinical significance:a. hemolytic anemia

b. transfusion reaction

c. PNH

d. severe burns and infections

e. malaria

f. strenuous exercise

Page 63: CLINICAL MICROSCOPY (Urinalysis)

Myoglobinuria

Clinical significance:a. muscular trauma/crush syndrome

b. prolonged coma

c. convulsions

d. muscle-wasting diseases

e. alcoholism/overdose

f. drug abuse

g. extensive exertion

Page 64: CLINICAL MICROSCOPY (Urinalysis)

Tests to Differentiate Hemoglobin and Myoglobin

Ammonium Sulfate Method Hb is precipitated by ammonium sulfate

Absorption Spectrophotometry Immunodiffusion Technique Protein Electrophoresis

Page 65: CLINICAL MICROSCOPY (Urinalysis)

Differentiation of Hematuria, Hemoglobinuria, and Myoglobinuria

Finding Red Cells Hemoglobin Myoglobin

Rgt. Strip Positive Positive Positive

Microscopic (RBCs)

Present Absent or few

Absent or few

Urine Appearance Cloudy red Clear red Clear red

Plasma Appearance

Normal Pink to red Normal

Total serum CK Normal Slight elevation

Marked elevation

Total serum LD Normal Elevated Elevated

LD1 and LD2 Normal Elevated Normal

LD4 and LD5 Normal Normal Elevated

Page 66: CLINICAL MICROSCOPY (Urinalysis)

VI. Bilirubin Clinical Significance

Hepatitis, cirrhosis, other liver disorders Biliary obstruction

Tests Foam-Shake Test Oxidation Test – acidic oxidation of bilirubin

into rainbow array of colors

Diazotization Test Ictotest Reagent Strip

Page 67: CLINICAL MICROSCOPY (Urinalysis)

VII. Urobilinogen found in urine in small amounts

Clinical Significance Early detection of liver disease Hemolytic disorders Hepatitis, cirrhosis, carcinoma

Tests Ehrlich’s Tube Test Schwartz-Watson Differentiation Test Reagent Strip

Page 68: CLINICAL MICROSCOPY (Urinalysis)

Urobilinogen Ehrlich-reactive Substances

Porphobilinogen

Chloroform Extraction

Urine (Top layer)

Chloroform(Bottom layer)

Colorless

Red

Red

Colorless

Red

Colorless

Butanol Extraction

Butanol (Top layer)

Urine (Bottom layer)

Red

Colorless

Red

Colorless

Colorless

Red

Watson-Schwartz Test Interpretation

Page 69: CLINICAL MICROSCOPY (Urinalysis)

Laboratory Findings in Various Types of Jaundice

Blood Urine Urine

Bilirubin Bilirubin Urobilinogen

Normal 0–1.3 mg/dL Negative ≤1 mg/dL

Hemolytic Increased Negative +++

Hepatic Increased + or - ++

Obstructive Normal +++ Normal

Page 70: CLINICAL MICROSCOPY (Urinalysis)

Urobilin – brown pigment which result from oxidation of urobilinogen upon exposure to light; tested when

urobilinogen is negative Porphyrins – cyclic compounds derived from ALA

Clinical Significance: Porphyrias Tests for Porphyrinuria

Ehrlich Test – requires the addition of acetylacetone prior to performing the test

Fluorescence – involves extraction into a mixture of glacial HAc and ethyl acetate and

examination of solvent layer

faint blue fluorescence = (-) violet, pink, or red = (+)

Page 71: CLINICAL MICROSCOPY (Urinalysis)

VIII. Nitrite Clinical Significance

Cystitis Pyelonephritis Evaluation of antibiotic therapy Monitoring of patients at high risk for

UTI Screening of urine culture specimens

Page 72: CLINICAL MICROSCOPY (Urinalysis)

IX. Leukocyte EsteraseClinical Significance

Bacterial and nonbacterial UTI Inflammation of the urinary tractScreening of urine culture

specimens

Page 73: CLINICAL MICROSCOPY (Urinalysis)

Urine Reference ValuesProperty Reference Value

Color Yellow

Transparency Clear

pH 5-7

Specific Gravity 1.001-1.035

Protein (albumin) Negative or Trace

Blood (hemoglobin) Negative

Nitrite Negative

LE Negative

Glucose Negative

Ketones Negative

Bilirubin Negative

Urobilinogen ≤1 mg/dL

Page 74: CLINICAL MICROSCOPY (Urinalysis)

Confirmatory Urinalysis TestsSubstance Test

Protein SSA Test

Blood Microscopic Examination

Hemoglobin, Myoglobin Centrifugation; then test supernatant with rgt.

strip for blood

Hemosiderin Rous Test

Glucose Clinitest

Bilirubin Ictotest

Urobilinogen Watson-Schwartz Test

Porphobilinogen Hoesch Test

Ascorbic Acid EM Quant

Page 75: CLINICAL MICROSCOPY (Urinalysis)

SPECIAL URINALYSIS SCREENING TESTS

Amino Acid Disorders

1. Phenylalanine-Tyrosine Disorders

a. Phenylketonuria

Tests: Ferric Chloride Test Phenistix DPNH Robert Guthrie Bacterial Inhibition

Test

Page 76: CLINICAL MICROSCOPY (Urinalysis)

b. Tyrosyluria Tests:

Millon’s Test Nitrosonaphthol Test Ferric Chloride Test Phenistix DPNH

Page 77: CLINICAL MICROSCOPY (Urinalysis)

c. Melanuria Tests:

Sodium nitroprusside Test - interference due to a red color from

acetone and creatinine can be avoided by adding glacial HAc

Ferric Chloride Test Acetest Blackberg and Wanger Test Ehrlich’s Test

Page 78: CLINICAL MICROSCOPY (Urinalysis)

d. Alkaptonuria

Tests: Ferric chloride Test Alkali Test Addition of silver nitrate or ammonium

hydroxide Benedict’s Test or Clinitest

Page 79: CLINICAL MICROSCOPY (Urinalysis)

2. Branched Chain Amino Acid Disorders

a. Maple Syrup Urine Disease Tests:

DNPH Amino Acid Chromatography Ferric Chloride Test Nitrosonaphthol Acetest

Page 80: CLINICAL MICROSCOPY (Urinalysis)

b. Organic Acidemias Isovaleric Acidemia

DNPH Acetest Chromatography

Propionic Acidemia DNPH Acetest

Methylmalonic Acidemia DNPH Acetest p-nitroaniline

Page 81: CLINICAL MICROSCOPY (Urinalysis)

3. Tryptophan Disorders

a. Indicanuria

Clinical Significance: Obstruction Presence of bacteria Malabsorption syndrome

b. Hartnup’s Disease production of blue color when indican is

oxidized upon exposure to air

Page 82: CLINICAL MICROSCOPY (Urinalysis)

c. 5-HIAA Tests:

Ferric Chloride Test Sjoerdsma Test.

Clinical Significance: Elevated in malignancy involving

Argentaffin cells

Page 83: CLINICAL MICROSCOPY (Urinalysis)

4. Cystine Disordersa. Cystinuria Tests:

+ Cystine crystals Cyanide nitroprusside

b. CystinosisTests: Cyanide nitroprusside Clinitest

c. HomocystinuriaTests: Cyanide nitroprusside Silver nitroprusside

Page 84: CLINICAL MICROSCOPY (Urinalysis)
Page 85: CLINICAL MICROSCOPY (Urinalysis)

Mucopolysaccharide Disorders Hurler’s Syndrome Hunter’s Syndrome San Filippo’s Syndrome

Tests: Acid Albumin CTAB Turbidity Test Metachromatic Staining Spot Test

Page 86: CLINICAL MICROSCOPY (Urinalysis)

Purine DisordersLesch-Nyhan Disease

lack of the enzyme HGPT Manifestations: severe motor defects,

mental retardation, tendency toward self-destruction, gout and renal calculi, orange sand in diapers

Page 87: CLINICAL MICROSCOPY (Urinalysis)

MICROSCOPIC EXAMINATION

Page 88: CLINICAL MICROSCOPY (Urinalysis)

Types of Microscope Bright Field – objects appear dark against a light

background Phase Contrast – works by retardation of light

rays diffused by the object in focus

Polarizing – used to confirm the identification of fat droplets, oval fat bodies, and fatty casts

Interference Contrast – object appears bright against a dark background but without the diffraction halo associated with Phase Contrast Microscope

Page 89: CLINICAL MICROSCOPY (Urinalysis)

Microscopic Sediment StainsSternheimer-Malbin0.5% Toluidine BlueSudan IIIOil Red OPrussian BlueHansel Stain

Page 90: CLINICAL MICROSCOPY (Urinalysis)

Reference Values for Urine Sediment

Constituent Reference Value

Red Blood Cells 0-2/hpf

White Blood Cells 0-5/hpf (female>male)

Casts 0-2 hyaline/hpf

Squamous Epithelial Cells Few/hpf

Transitional Epithelial Cells Few/hpf

Renal Tubular Epithelial Cells Few/hpf

Bacteria Negative

Yeast Negative

Abnormal crystals Negative

Page 91: CLINICAL MICROSCOPY (Urinalysis)

Standardization of Procedure

1. Urine Volume – 12 mL

2. Time of Centrifugation – 5 minutes

3. Speed of Centrifugation Relative Centrifugal Force of 400 g

4. Volume of Sediment Examined – 20 μL

5. Reporting Format

Page 92: CLINICAL MICROSCOPY (Urinalysis)

Reporting System for Urine SedimentAverage Number per Low-Power Field

Casts Neg 0-2 2-5 5-10 10-25 25-50 >50

Abnormal crystals Neg 0-2 2-5 5-10 10-25 25-50 >50

Squamous ECs Few Moderate Many

Mucus Present

Average Number per High-Power Field

Red Blood Cells 0-2 2-5 5-10 10-25 25-50 50-100 >100

White Blood Cells 0-2 2-5 5-10 10-25 25-50 50-100 >100

Normal Crystals Few Moderate Many

Epithelial Cells Few Moderate Many

Miscellaneous Few Moderate Many

Sperm Present

Page 93: CLINICAL MICROSCOPY (Urinalysis)

Organized Sediments

Page 94: CLINICAL MICROSCOPY (Urinalysis)

Red Blood Cells

•Normal appearance

•N.V.

•Variations in shape and appearance

•Clinical Significance

Page 95: CLINICAL MICROSCOPY (Urinalysis)

Non-glomerular hematuria: RBCs are uniform in size and shape but

show two populations of cells because a small number have lost

their hemoglobin pigment.

Page 96: CLINICAL MICROSCOPY (Urinalysis)

Glomerular hematuria: RBCs are small and vary in size, shape, and

hemoglobin content.

Page 97: CLINICAL MICROSCOPY (Urinalysis)

White Blood Cells

Amoeboid

Bacteria

•Normal appearance

•N.V.

•Clinical Significance

Page 98: CLINICAL MICROSCOPY (Urinalysis)

•Glitter cells

•Eosinophils

•Mononuclear cells

Page 99: CLINICAL MICROSCOPY (Urinalysis)

Squamous Epithelial Cells

Page 100: CLINICAL MICROSCOPY (Urinalysis)

• Clue Cells

Page 101: CLINICAL MICROSCOPY (Urinalysis)

Transitional Epithelial Cells

smaller than squamous cells, spherical, caudate, or polyhedral with central nucleus

Clinical Significance Transitional that appear singly, in pairs,

or in clumps Transitional cells with abnormal

morphology

Page 102: CLINICAL MICROSCOPY (Urinalysis)

Renal Tubular Epithelial Cells

•Clinical Significance

•Oval Fat Bodies

•Bubble Cells

Page 103: CLINICAL MICROSCOPY (Urinalysis)

Casts

Mechanisms of Cast Formation

Page 104: CLINICAL MICROSCOPY (Urinalysis)

Hyaline Cast

•Strenuous exercise, dehydration, heat exposure, emotional stress

•Acute glomerulonephritis, pyelonephritis, chronic renal disease, CHF

Page 105: CLINICAL MICROSCOPY (Urinalysis)

Red Blood Cell Cast

Page 106: CLINICAL MICROSCOPY (Urinalysis)
Page 107: CLINICAL MICROSCOPY (Urinalysis)

WBC Cast

•Epithelial Cell Cast

Page 108: CLINICAL MICROSCOPY (Urinalysis)

Coarsely Granular Cast

Page 109: CLINICAL MICROSCOPY (Urinalysis)

Finely Granular Cast

Page 110: CLINICAL MICROSCOPY (Urinalysis)

Waxy Cast

•Fatty Cast

•Broad Cast

Page 111: CLINICAL MICROSCOPY (Urinalysis)

Bacteria

Page 112: CLINICAL MICROSCOPY (Urinalysis)

Yeast Cells

There are no PMNs seen suggestive of contamination and

not of UTI.

Page 113: CLINICAL MICROSCOPY (Urinalysis)

Mucus Thread

Page 114: CLINICAL MICROSCOPY (Urinalysis)

Unorganized Sediments

Page 115: CLINICAL MICROSCOPY (Urinalysis)

CrystalsNormal Crystals in Acidic Urine

1. Amorphous Urates2. Uric Acid3. Sodium Urates4. Calcium Sulfates5. Calcium Oxalate6. Hippuric Acid

Page 116: CLINICAL MICROSCOPY (Urinalysis)

Amorphous Urates

Page 117: CLINICAL MICROSCOPY (Urinalysis)

Uric Acid

Page 118: CLINICAL MICROSCOPY (Urinalysis)

Dihydrate Calcium Oxalate

Page 119: CLINICAL MICROSCOPY (Urinalysis)

Normal Crystals in Alkaline Urine

1. Amorphous Phosphate

2. Calcium Carbonate

3. Ammonium biurate

4. Calcium Phosphate

5. Triple Phosphate

Page 120: CLINICAL MICROSCOPY (Urinalysis)

Amorphous Phosphate

Page 121: CLINICAL MICROSCOPY (Urinalysis)

Calcium Carbonate

Page 122: CLINICAL MICROSCOPY (Urinalysis)

Ammonium biurate

Page 123: CLINICAL MICROSCOPY (Urinalysis)

Calcium phosphate

Page 124: CLINICAL MICROSCOPY (Urinalysis)

Triple phosphate

Page 125: CLINICAL MICROSCOPY (Urinalysis)

Abnormal Crystals of Metabolic Origin

Cystine Cholesterol Leucine Tyrosine Bilirubin Hemosiderin

Abnormal Crystals of Iatrogenic Origin

Sulfonamides Radiographic

contrast media Ampicillin Acyclovir Indinavir sulfate

Page 126: CLINICAL MICROSCOPY (Urinalysis)

Cystine

Page 127: CLINICAL MICROSCOPY (Urinalysis)

Cholesterol

Page 128: CLINICAL MICROSCOPY (Urinalysis)

Leucine

Page 129: CLINICAL MICROSCOPY (Urinalysis)

Tyrosine

Page 130: CLINICAL MICROSCOPY (Urinalysis)

Sulfa Crystals

Page 131: CLINICAL MICROSCOPY (Urinalysis)

Starch